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aBstraCt
BaCkground: The purpose of this paper was to report a case of retrobulbar optic neuritis as the first manifestation 
of multiple sclerosis, with atypical presentations which include a sudden painless reduction in vision, without optic 
disc swelling and presence of unilateral inferior altitudinal visual field defect.
Case report: A 17-year-old girl presented to our clinic with right eye sudden painless drop in visual acuity to co-
unting finger associated with headache. Her right eye optic nerve function tests were positive, but her optic disc was 
not swollen. Bjerrum’s visual field chart noted right eye unilateral inferior altitudinal visual field defect with foveal 
involvement. Her blood investigations were normal, and magnetic resonance imaging (MRI) of brain and orbit was 
suggestive of multiple sclerosis. She was commenced on three days of high dose intravenous steroi, and was referred 
to neuromedical team for further management. At 3-month follow up, her right eye visual acuity improved to 6/6 
with the restoration of normal colour vision. 
ConClusions: In presence of atypical presentation of optic neuritis, multiple sclerosis must be thought of especially 
in young patients. Hence early co-management with neuromedical discipline is important to reduce the frequency 
and severity of attacks in the future.
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introduCtion
Optic neuritis (ON) refers to an inflammatory 
demyelinating disorder of the optic nerve, charac-
terized by monocular, painful and subacute vision 
drop over a period of one to two weeks [1–3], com-
monly affecting young healthy females at mean age 
of 36 [4]. Rarely, ON may have atypical presenta-
tions such as the onset of fewes than 20 years old, 
painless and sudden onset of reduction in visual 
acuity [1, 2]. 
In addition, ON can present with any type of 
nerve-fibre-bundle-related visual field (VF) defect. 
Keltner et al summarized that diffuse and central VF 
defect predominated in the affected eye at the first 
visit, then mainly partial arcuate, paracentral, and 
arcuate VF defects during follow-up [5]. Although 
the pattern of VF defect is not diagnostic of ON, al-
titudinal VF defect remains uncommon and should 
be further investigated for other aetiologies [2]. 
Demyelinating ON can occur in isolation or be 
associated with multiple sclerosis (MS) or neuro-
myelitis optica (NMO) [3]. Multiple sclerosis is an 
inflammatory demyelinating disease of the central 
nervous system characterized by multicentric in-
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flammation and myelin destruction. On the other 
hand, NMO is an antibody-mediated disorder of 
the central nervous system usually attacking the 
optic nerves and spinal cord, involving both gray 
and white matters [1]. 
In this article, we will discuss on the atypical 
presentations of ON and the uncommon visual field 
defects that may be present in ON. We also suggest 
that MS should be suspected in the case of young 
healthy female and refer to neuromedical team early 
for co-management to further reduce the risk of 
recurrence. 
Case report
A 17-year-old Malay girl who has no known 
medical illness, noticed a sudden painless drop in 
visual acuity of her right eye right after she woke 
up from her nap. It was accompanied by on and 
off dull frontal headache. She denies of ocular pain 
upon eye movement. Furthermore, she volunteered 
the history of recent viral flu one week ago, which 
lasted for four days, and has resolved at the time 
of presentation. There were no preceding flash or 
floaters, and patient denies of any trauma or insect 
bites. She also denies of body weakness, raised in-
tracranial pressure symptoms, fever or any constitu-
tional symptoms. She has no past ocular history and 
her family history was unremarkable. 
On examination, her visual acuity was hand 
movement in the right eye and that was 6/6 in 
the left eye. The relative afferent pupillary defect 
(RAPD) was grade I positive on the right eye, with 
a light brightness of 70% and red desaturation of 
30%. Ishihara colour vision test was unable to be 
performed over the right eye due to the poor vi-
sion. Her anterior segment and intraocular pressure 
were normal. Her optic discs were not swollen nor 
hyperemic and no retinitis patch nor vitritis seen in 
posterior pole. Her extraocular muscle movements 
were intact and painless, and no other cranial nerves 
affected. The rest of her neurological examination 
was unremarkable.
B-scan ultrasonography showed thickened right 
eye retroorbital optic nerve measuring 6.3 mm 
while that of the left eye measured 4.0 mm. We 
proceeded with Bjerrum’s screen chart as our patient 
had poor visual acuity and was unable to fixate on 
the stimulus target. Her Bjerrum’s screen chart re-
vealed right eye unilateral inferior altitudinal defect 
with foveal involvement, and the fellow eye showed 
supero-nasal arcuate defect (Fig. 1). 
Her full blood count, renal function, erythro-
cyte sedimentation rate, C-reactive protein, folate 
and B12 level taken were within normal ranges. In 
addition, her serum anti-aquaporin-4 antibody re-
turned negative. Her autoimmune screening and 
infective screening for venereal disease, human im-
munodeficiency virus (HIV), hepatitis B and C 
were non-reactive as well. 
Magnetic resonance imaging (MRI) of brain and 
orbit reported multiple hyperintense lesions in pe-
Figure 1. Bjerrum’s Screen Chart of the (a) right and (B) left eye at initial visit 
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riventricular, juxtacortical and pericallosal region 
consistent with multiple sclerosis with dissemina-
tion in space, and no abnormal enhancement of 
optic nerve was seen (Fig. 2).  
Furthermore, lumbar puncture was performed. 
The opening pressure was normal, and the cer-
ebrospinal fluid (CSF) sample was clear, no signs 
of infection. Her CSF for anti-aquaporin-4 anti-
body was negative. On the other hand, her CSF 
electrophoresis revealed oligoclonal band with 
raised IgG index, which is consistent with mul-
tiple sclerosis.  
Our patient was initially diagnosed with ret-
robulbar optic neuritis was secondary to viral flu 
in view of the history of recent flu prior to her 
presentation. However, the presence of bilateral 
visual field (VF) defect prompted us to proceed 
with contrast enhanced computerized tomography 
CECT brain and orbit to rule out the presence of 
space-occupying lesion. As there was no significant 
abnormality seen, we then proceeded with MRI 
brain and orbit, which suggested the diagnosis of 
multiple sclerosis. This is consistent with her CSF 
electrophoresis that revealed oligoclonal band with 
raised IgG index. This fulfils the Mcdonald criteria 
for the diagnosis of multiple sclerosis (MS) whereby 
she has one episode of attack, dissemination of space 
revealed by MRI and oligoclonal band present in 
CSF electrophoresis.  
Other than MS, neuromyelitis optica spectrum 
disorder (NMOSD) is also commonly associated 
with ON in young healthy females. However, this 
was ruled out by the absence of anti-aquaporin-4 an-
tibody in both serum and CSF. Although painless 
monocular vision loss and unilateral inferior alti-
tudinal defect also paints a picture of non-arteritic 
anterior ischemic optic neuropathy (NAION), this 
does not fit her age group and there is lack of 
ischemic risk factors such as diabetes, hypertension 
or any history of major surgery to justify the diag-
nosis.
She was referred to neuromedical team, and was 
started on methylprednisolone 250 mg i.v. 6-hourly 
for 3 days, subsequently discharged home with oral 
Prednisolone 1mg/kg/day and slowly tapered over 
a period of 6 weeks as per neuromedical plan. Her 
right eye visual acuity has improved to 3/60 after 
completing 3 days of methylprednisolone treat-
ment.
At 3-month follow up, her vision has improved 
to 6/6 both eyes, with normal colour vision. There 
was no more relative afferent pupillary defect 
(RAPD) present. Her anterior segment, intraocular 
pressure and posterior segment were normal, no 
Figure 2. High intensity lesions at (a) periventricular, (B) juxtacortical and (C) pericallosal region
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disc pallor nor swelling noted. This time around we 
monitored her VF defect with Humphrey’s visual 
field. Her right eye VF has cleared up leaving nasal 
step defect with some patchy loss, and left eye re-
vealed superior arcuate defect (Fig. 3). 
disCussion
Wilhelm and Schabet [4] described a typical 
presentation of demyelinating ON as occurrence 
between age 18 to 50, unilateral, peribulbar pain, 
and improvement of vision after treatment. The 
mean age of onset is 36, and demyelinating ON is 
rare in patients below 18 years old. According to 
Kale [2], only 8% of patients with ON presented 
with painless vision loss, which is similar to our 
patient’s presentation. This could be explained by 
the inflammation lying in the intracranial portion 
of optic nerve [4]. Gaier et al [1] and Hoorbakht et 
al [7] suggested that painless visual loss should raise 
suspicion for other causes such as non-arteritic ante-
rior ischemic optic neuropathy (NAION) or Leber’s 
hereditary optic neuropathy (LHON). However, 
both diagnoses did not fit our patient’s age, gender, 
and risk factors. 
Optic neuritis can be divided into:
 — 1 — retrobulbar ON with normal disc appea-
rance;
 — 2 — papillitis involving the anterior aspect of 
the optic nerve with optic disc swelling;
 — 3 — perineuritis with the involvement of the 
optic nerve sheath;
 — 4 — neuroretinitis, with optic disc swelling and 
macular star [3]. Among these subtypes, retrobul-
bar and papillitis ON are more commonly associa-
ted with MS. ON that present in isolation acco-
unts for 20% of the initial presentation of MS [2]. 
From the Optic Neuritis Treatment Trial 
(ONTT) [8], we learnt that the patients presented 
with various types of VF defect, predominantly dif-
fuse (66%) and central field loss (27%) on the 
affected eye during their first presentation. Our pa-
tient presented with unilateral inferior altitudinal 
field defect on the affected eye during initial presen-
tatio, and then transformed into a nasal step-defect 
during follow up. This is uncommon as Keltner et al 
[5] concluded that only 8% of the participants from 
the ONTT presented with altitudinal field defect 
initially, and no more than 2% developed nasal step 
defect during their follow up. 
Figure 3. Humphrey visual field 24-2 of (a) right eye and (B) left eye at 3-month follow-up
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Furthermore, Keltner et al [5] revealed that 75% 
of the patients developed VF defect on the fellow 
eye during follow up, predominantly partial arcuate, 
paracentral, and arcuate defects. In this case, our 
patient developed superior arcuate defect over her 
fellow eye, suggesting the involvement of the optic 
nerve fibre bundle. Despite the limited use of VF 
in aiding diagnosis, Kale et al [2] suggested that the 
presence of altitudinal defect warrant consideration 
of other differential diagnosis. In this case, we have 
proceeded with urgent brain imaging and managed 
to rule out space occupying lesions and life-threat-
ening intracranial pathologies.  
In 1970, Hayreh [9] suggested that altitudinal 
VF defect without retinal lesion is caused by disrup-
tion in the posterior ciliary artery circulation. De-
spite the pathophysiology of ON remains unclear, 
it is postulated to result from inflammation and 
demyelination of the optic nerve [3]. Cytokines and 
other inflammatory mediators are released when 
activated peripheral T-cells cross the blood brain 
barrier, causing destruction of myelin, neural cell 
death and axonal degeneration [3, 7]. Here we sus-
pect that either the inflammation of the optic nerve 
itself or the secondary perfusion defect caused by 
the inflammation of the optic nerve has resulted in 
an altitudinal VF defect in our patient. 
Brain MRI is helpful diagnostically and prog-
nostically to determine the risk of developing MS 
for patients with ON based on the number of de-
myelinating white matter lesions [3]. ONTT con-
cluded that the risk of patients with ON developing 
MS by 15 years was 25% if their MRI brain was 
normal at time of diagnosis, and the risk triples to 
78% if their MRI brain has more than three lesions 
[8]. In our patient’s circumstance, she has lesions 
at periventricular, juxtacortical and pericallosal re-
gions, and CSF electrophoresis has confirmed her 
diagnosis of MS. 
However, no enhancement of optic nerve was 
seen in our patient’s MRI. According to Kupersmith 
et al [10], enhancement of the optic nerve has a sen-
sitivity of 94% in acute optic neuritis, and only 5% 
of patients with ON did not have enhancement of 
the affected optic nerve. Nonetheless, there wae no 
significant difference in terms of visual acuity and 
colour vision between those with and without optic 
nerve enhancement [10]. 
Intravenous methylprednisolone (IVMP) is 
recommended when there is monocular involve-
ment, significant bilateral visual loss, or when fast 
recovery to normal visual acuity is required [3, 
7]. Once systemic infection is ruled out, IVMP 
in a dose of 250 mg 6-hourly should be com-
menced over a 3-day course, followed by 11 days 
of daily oral prednisone (1 mg/kg/day) as per 
recommended by ONTT [8]. The main aim of 
treatment is to reduce the frequency and severity 
of attacks, and prevention of axonal loss in both 
ON and MS [7]. 
At 1-year follow-up, 94% of the patients who 
received IVMP in ONTT regained vision of 6/12 or 
better but subtle symptoms such as blurred vision 
may persist even with VA of > 6/6 [7]. Our patient 
has already achieved visual acuity of 6/6 with nor-
mal colour vision at 3-month follow-up. 
ConClusion
Optic neuritis is a disease with many fac-
es. Atypical presentations such as painless acute 
vision loss prompt other differential diagnoses 
but this does not rule out ON. It may also present 
with inferior altitudinal VF defect, which war-
rants further imaging to exclude other intracranial 
pathologies as this is an uncommon presenta-
tion. Brain MRI is important diagnostically and 
prognostically in monitoring disease progression. 
Last but not least, multiple sclerosis should be 
suspected in the case of young healthy female as 
early diagnosis and early co-management with 
neuromedical team reduces the frequency and se-
verity of recurrence. 
Consent for publication
The case patient had consented for publication of 
this case report, including the usage of her fundus 
photograph, OCT scans and recorded video of the 
surgery.   
Conflicg of interests
The authors declare that there is no conflict of in-
terest. 
Funding acknowledgement
The authors received no financial support for the 
research, authorship, and/or publication of this ar-
ticle.
reFerenCes
1. Gaier eD, Boudreault K, rizzo JF, et al. atypical optic Neuritis. Curr 
Neurol Neurosci rep. 2015; 15(12): 76, doi:  10.1007/s11910-015-
0598-1, indexed in pubmed: 26467052.
2. Kale N. optic neuritis as an early sign of multiple sclerosis. eye 
Brain. 2016; 8: 195–202, doi:  10.2147/eB.S54131, indexed in 
pubmed: 28539814.
Cheau Wei Chin, Mohammad Fathi Ismail on with unilateral inferior altitudinal VF defect in Ms
135www.journals.viamedica.pl/ophthalmology_journal
3. pau D, al Zubidi Nu, Yalamanchili S, et al. optic neuritis. eye. 
2011; 25(7): 833–842, doi:  10.1038/eye.2011.81, indexed in 
pubmed: 21527960.
4. Wilhelm H, Schabet M. the Diagnosis and treatment of optic Neuritis. 
Dtsch arztebl Int. 2015; 112(37): 616–25; quiz 626, doi:  10.3238/
arztebl.2015.0616, indexed in pubmed: 26396053.
5. Keltner JL, Johnson Ca, Cello Ke, et al. optic Neuritis Study Group. 
Visual field profile of optic neuritis: a final follow-up report from the 
optic neuritis treatment trial from baseline through 15 years. arch 
ophthalmol. 2010; 128(3): 330–337, doi:  10.1001/archophthal-
mol.2010.16, indexed in pubmed: 20212204.
6. trapp BD, peterson J, ransohoff rM, et al. axonal transection in the 
lesions of multiple sclerosis. N engl J Med. 1998; 338(5): 278–285, 
doi: 10.1056/NeJM199801293380502, indexed in pubmed: 9445407.
7. Hoorbakht H, Bagherkashi F. optic neuritis, its differential diagnosis 
and management. open ophthalmol J. 2012; 6: 65–72, doi: 10.2174/
1874364101206010065, indexed in pubmed: 22888383.
8. optic Neuritis Study Group. Multiple sclerosis risk after optic 
neuritis: final optic neuritis treatment trial follow-up. arch Neurol. 
2008; 65(6): 727–732, doi:  10.1001/archneur.65.6.727, indexed in 
pubmed: 18541792.
9. Hayreh SS. pathogenesis of visual field defects. role of the ciliary 
circulation. Br J ophthalmol. 1970; 54(5): 289–311, doi:  10.1136/
bjo.54.5.289, indexed in pubmed: 4987892.
10. Kupersmith MJ, alban t, Zeiffer B, et al. Contrast-enhanced MrI 
in acute optic neuritis: relationship to visual performance. Brain. 
2002; 125(pt 4): 812–822, doi:  10.1093/brain/awf087, indexed in 
pubmed: 11912114.
